By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Helix Biopharma Corp. 

3-305 Industrial Parkway

Aurora  Ontario  L4G 6X7  Canada
Phone: 905-841-2300-Ext-232 Fax: 905-841-2244




Company News
Helix Biopharma (TSX:HBP) Closes CAD4.7 Million Private Placement Financing 5/2/2016 10:56:15 AM
Helix Biopharma (TSX:HBP) Release: Trial Steering Committee Recommends Initiation Of Phase II L-DOS47 Study In Non-Small Cell Lung Cancer 4/25/2016 10:30:06 AM
Helix Biopharma (TSX:HBP) Announces Important Additions To Its Leadership Team 4/21/2016 11:11:41 AM
Helix Biopharma (TSX:HBP) Announces The Receipt Of Subscription Agreements Totalling CAD4.7 Million For Private Placement Financing 4/18/2016 11:57:09 AM
Helix Biopharma (TSX:HBP) CEO Steps Down for Personal Reasons 3/30/2016 6:34:30 AM
Helix Biopharma (TSX:HBP) Announces Second Quarter Fiscal 2016 Results 3/17/2016 10:26:07 AM
Helix Biopharma (TSX:HBP) Reports On Advancement Of Its L-DOS47 Phase I/II Study In Poland 3/9/2016 12:04:11 PM
Helix Biopharma (TSX:HBP) Reports On Advancement Of Its Lung Cancer Drug Candidate L-DOS47 3/4/2016 10:49:32 AM
Helix Biopharma (TSX:HBP) Announces Appointment Of New Directors To The Board Of Directors 2/1/2016 11:35:34 AM
Helix Biopharma (TSX:HBP) Initiates Enrollment In The Second Dosing Cohort Of U.S. Combination Treatment Study Of Its Lung Cancer Drug Candidate L-DOS47 1/22/2016 10:22:29 AM